C2RS34 Stock Chart & Stats
R$30.45
R$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week RangeR$22.00 - R$52.30
Previous CloseN/A
VolumeN/A
Average Volume (3M)288.00
Market Cap
R$23.49B
Enterprise ValueR$14.78K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.01
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding96,448,790
10 Day Avg. Volume259
30 Day Avg. Volume288
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh News
C2RS34 FAQ
What was CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh’s price range in the past 12 months?
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh lowest stock price was R$22.00 and its highest was R$52.30 in the past 12 months.
What is CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh’s market cap?
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh’s market cap is R$23.49B.
When is CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh’s upcoming earnings report date?
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh’s upcoming earnings report date is Nov 04, 2026 which is in 91 days.
How were CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh’s earnings last quarter?
Currently, no data Available
Is CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh overvalued?
According to Wall Street analysts CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh’s price is currently Undervalued.
Does CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh pay dividends?
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh does not currently pay dividends.
What is CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh’s EPS estimate?
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh have?
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh has 96,448,790 shares outstanding.
What happened to CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh?
Currently, no hedge funds are holding shares in BR:C2RS34
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CRISPR Therapeutics AG Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (C2RS34) Earnings & Revenues
Denali Therapeutics Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh
―
Hypera S.A.
―
Ultragenyx Pharmaceutical Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh
―
Teleflex Incorporated Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh
―
DENTSPLY SIRONA, Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh
―